Evnin Luke's Form 4 filing
Werewolf Therapeutics, Inc. (HOWL) · filed Jan 7, 2026
- Accession no.
- 0001134657-26-000002
- Filed
- Jan 7, 2026
- Trade date
- Jan 5-7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $45.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evnin LukeCIK 0001134657 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Common Stock | SSaleDisposed | −18,378 | $0.64 | −$11,761.92 | 2,453,919 | Indirect | |
| Jan 6, 2026 | Common Stock | SSaleDisposed | −40,761 | $0.65 | −$26,494.65 | 2,413,158 | Indirect | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −11,915 | $0.64 | −$7,625.6 | 2,401,243 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.